Topic Government Bids & RFPs

The offer due date is July 1, 2026, at 3:30 PM CT. Proposals must be submitted via email to ***@***. *. * and ***@***. *. * with a scanned PDF copy of the signed **** suggests that offerors submit their proposals well before the deadline and confirm receipt of all attachments with the contracting officer listed on the ****.

Payment terms are not explicitly detailed for direct payment from the government to the contractor. Instead, contractors will receive payments from the Prime Vendor (PPV) programs. Payment terms, time and place of delivery to ppv distribution centers, and other business-to-business agreement terms shall be agreed upon between the ppv contractors and the contractor awarded a contract from this solicitation.

The contract includes a warranty clause stating: The contractor warrants and implies that the items delivered under this contract are merchantable and fit for use for the particular purpose described in this contract.

Offers will be evaluated in accordance with the policies and procedures of FAR Part 12, Part 15, and Part 25. one award will be made for line item 1 for the base year and all four option years.

Offerors must submit a price for the base year and all four option years. If the offeror is not the manufacturer, a letter of commitment from the manufacturer is required. Offerors must also provide a unique 11-digit NDC number for each offered drug. an acceptable letter of commitment is required from all distributorofferors to be eligible for award.

Failure to provide awarded product meeting all solicitation/contract requirements by the ordering period start date may result in contract termination for cause. Willful failure or refusal to furnish required reports, or falsification thereof, shall constitute sufficient cause for terminating the contract. failure to timely pay the cost recovery fee constitutes a contract debt to the united states government.

Proposals that fail to include a price for the base year and each of the four option years for line item 1 may be rejected. Offers that fail to provide a unique 11-digit NDC number may be rejected. offers of covered drugs including biologics that fall within 21 cfr **** will only be considered for award if the offeror has an executed ma and ppa which includes the proposed drug productsndcs on file with the va national acquisition center, fss in accordance with 38 u. s. c. 8126h4b.

The performance period for the base contract is from 01 September 2026 to 31 August 2027, with four option years extending to 31 August 2031. The ability to provide emails covering topics as requested by msc subscribers. such emails to be on a daily basis, and more often when congress is in session.

This announcement will remain open for approximately one year from the date of publication, or until replaced by a successor BAA. White papers may be submitted at any time during this period, formal proposals are by invitation only. This announcement replaces **** dated 3 Oct 2022.

Awards will be made based on technical merit, importance to agency programs, and fund availability. Cost realism and reasonableness will also be considered. The primary basis for selecting proposals for acceptance will be technical merit, importance to agency programs, and fund availability.

All responsible sources from academia, industry, and the research community may submit proposals. Federally Funded Research and Development Centers (FFRDCs) and Navy laboratories are not eligible to receive awards but can team with eligible principal offerors. All responsible sources from academia, industry and the research community may submit proposals under this baa.

NRL may remove offerors from award consideration if agreement on award terms, conditions, and cost/price cannot be reached within a reasonable time, or if the offeror fails to timely provide requested information. NRL reserves the right to remove offerors from award consideration when the parties fail to reach agreement on award terms, conditions, and cost price within a reasonable time, or when the offeror fails to timely provide requested or required additional information.

Proposers must have cognizant security agency approved facilities, information systems, and appropriately cleared personnel to perform at the proposed classification level.

Failure to adhere to classified submission requirements, including facility and personnel clearances, may lead to disqualification.